Natixis’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,200
| Closed | -$26.6K | – | 1055 |
|
|
2023
Q4 | $26.6K | Hold |
1,200
| – | – | ﹤0.01% | 845 |
|
|
2023
Q3 | $25.9K | Sell |
1,200
-1,996
| -62% | -$43.1K | ﹤0.01% | 845 |
|
|
2023
Q2 | $216K | Buy |
+3,196
| New | +$216K | ﹤0.01% | 719 |
|
|
2022
Q1 | – | Sell |
-4,707
| Closed | -$1.66M | – | 1211 |
|
|
2021
Q4 | $1.66M | Sell |
4,707
-3,301
| -41% | -$1.16M | 0.01% | 819 |
|
|
2021
Q3 | $2.05M | Buy |
8,008
+440
| +6% | +$112K | 0.01% | 724 |
|
|
2021
Q2 | $5.04M | Hold |
7,568
| – | – | 0.02% | 379 |
|
|
2021
Q1 | $6.57M | Hold |
7,568
| – | – | 0.02% | 458 |
|
|
2020
Q4 | $7.02M | Sell |
7,568
-1,328
| -15% | -$1.23M | 0.03% | 457 |
|
|
2020
Q3 | $9.15M | Buy |
+8,896
| New | +$9.15M | 0.07% | 197 |
|
|
2018
Q4 | – | Sell |
-541
| Closed | -$821K | – | 729 |
|
|
2018
Q3 | $821K | Buy |
+541
| New | +$821K | ﹤0.01% | 586 |
|